{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:31:25Z","timestamp":1777113085491,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020884","name":"QIAGEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ijid.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T16:31:08Z","timestamp":1678293068000},"page":"S30-S33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-8626","authenticated-orcid":false,"given":"Pei Min","family":"Thong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Tarng","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabel J.W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine W.M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.02.009_bib0001","article-title":"The impact of COVID-19 on essential health service provision for noncommunicable diseases in the South-East Asia region: a systematic review","volume":"1","author":"Gadsden","year":"2022","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.ijid.2023.02.009_bib0002","series-title":"Self-study modules on tuberculosis modules 2 epidemiology of tuberculosis","year":"2019"},{"key":"10.1016\/j.ijid.2023.02.009_bib0003","series-title":"Global tuberculosis report 2021","year":"2021"},{"key":"10.1016\/j.ijid.2023.02.009_bib0004","series-title":"Global tuberculosis report 2022","year":"2022"},{"key":"10.1016\/j.ijid.2023.02.009_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11154-021-09630-8","article-title":"Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis","volume":"22","author":"Corona","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ijid.2023.02.009_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.46234\/ccdcw2020.032","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020","volume":"2","year":"2020","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.ijid.2023.02.009_bib0007","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0009","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.12998\/wjcc.v9.i28.8327","article-title":"Diabetes mellitus and COVID-19: understanding the association in light of current evidence","volume":"9","author":"Sen","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ijid.2023.02.009_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0011","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12916-022-02656-y","article-title":"Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2023.02.009_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020\u2013June 28, 2021","volume":"71","author":"Barrett","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2023.02.009_bib0013","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/dom.14099","article-title":"Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ijid.2023.02.009_bib0014","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4239\/wjd.v13.i9.729","article-title":"COVID-19 associated diabetes mellitus: a review","volume":"13","author":"Gavkare","year":"2022","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ijid.2023.02.009_bib0015","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s42255-022-00691-w","article-title":"COVID-19 and diabetes \u2014 where are we now?","volume":"4","author":"Gro\u00df","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.ijid.2023.02.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01786-2021","article-title":"Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study","volume":"58","author":"Migliori","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2023.02.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100603","article-title":"The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis","volume":"28","author":"Cilloni","year":"2020","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.ijid.2023.02.009_bib0018","article-title":"Tuberculosis and COVID-19 co-infection: description of the global cohort","volume":"59","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2023.02.009_bib0019","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.ijid.2021.02.090","article-title":"Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2","volume":"113","author":"Petrone","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149125","article-title":"Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection","volume":"131","author":"Riou","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2023.02.009_bib0021","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0022","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ajpath.2021.03.011","article-title":"Coronavirus activates an altruistic stem cell-mediated defense mechanism that reactivates dormant tuberculosis: implications in coronavirus disease 2019 pandemic","volume":"191","author":"Pathak","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0023","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/ijms22073773","article-title":"Corticosteroids for COVID-19 therapy: potential implications on tuberculosis","volume":"22","author":"Gopalaswamy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijid.2023.02.009_bib0024","series-title":"IDF diabetes atlas","year":"2021"},{"key":"10.1016\/j.ijid.2023.02.009_bib0025","first-page":"288","article-title":"Diabetes and tuberculosis: a syndemic complicated by COVID-19","volume":"157","author":"Antonio-Arques","year":"2021","journal-title":"Med Clin (Engl Ed)"},{"key":"10.1016\/j.ijid.2023.02.009_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4269\/ajtmh.2008.79.541","article-title":"Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes","volume":"79","author":"Restrepo","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2023.02.009_bib0027","doi-asserted-by":"crossref","first-page":"e46477","DOI":"10.7554\/eLife.46477","article-title":"Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity","volume":"8","author":"Kumar","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ijid.2023.02.009_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jinf.2016.08.021","article-title":"Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors","volume":"74","author":"Kumar","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2023.02.009_bib0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1513\/AnnalsATS.201305-112OC","article-title":"Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines","volume":"10","author":"Kumar","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ijid.2023.02.009_bib0030","article-title":"Impact of intermediate hyperglycaemia as well as diabetes on immune dysfunction in tuberculosis","author":"Eckold","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.009_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16549716.2016.1264702","article-title":"Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden","volume":"10","author":"Zheng","year":"2017","journal-title":"Glob Health Action"},{"key":"10.1016\/j.ijid.2023.02.009_bib0032","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature13967","article-title":"Interception of host angiogenic signalling limits mycobacterial growth","volume":"517","author":"Oehlers","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2023.02.009_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2023.02.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006974","article-title":"Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis","volume":"14","author":"Xu","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2023.02.009_bib0035","article-title":"Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression","volume":"9","author":"C\u00e1ceres","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.009_bib0036","series-title":"Management of diabetes mellitus-tuberculosis: a guide to the essentialpractice","author":"Lin","year":"2019"},{"key":"10.1016\/j.ijid.2023.02.009_bib0037","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-8587(15)00042-X","article-title":"Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ijid.2023.02.009_bib0038","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s13410-017-0599-5","article-title":"Diabetes and tuberculosis in Mexico: results from epidemiological studies","volume":"38","author":"Mendoza-Almanza","year":"2018","journal-title":"Int J Diabetes Dev Ctries"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:35:25Z","timestamp":1746376525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"alternative-id":["S1201971223000553"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.02.009","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}